About Nova Diabetes Care
Nova Diabetes Care is an independent, wholly owned subsidiary of Nova Biomedical® and is the exclusive distributor of Nova Max® products in the United States.
About Nova Biomedical
Founded in 1976, Nova Biomedical is a world leader in the development and manufacturing of state-of-the-art medical devices, diagnostic equipment and specifically in vitro diagnostics. Employing over 800 people, including more than 125 scientists and engineers, Nova Biomedical occupies over 300,000 square feet of development, engineering and manufacturing space in Billerica and Waltham, Massachusetts.
In addition to the Nova Max® glucose monitors, we also make Stat Profile® blood gas, critical care analyzers. These are blood testing analyzers used for emergency testing on some of the most critically ill patients in the hospital. We also manufacture a variety of advanced technology diagnostic products for some of the world's largest and most successful healthcare companies. Some of our customers include Abbott, Baxter, Dade, Gambro, Johnson and Johnson, Medtronic MiniMed, and Smith and Nephew. These are all companies that have a worldwide reputation for providing their customers with products of exceptional quality and reliability. Their selection of Nova Biomedical as a key vendor is also an endorsement of our ability to provide products of exceptional quality, reliability and value to you.
Nova Biomedical is widely known as the world leader in whole blood critical care technology to hospitals because of our extensive offerings of over 46 different whole blood tests. We are proud of our reputation for providing these assays accurately and cost effectively.
For more information about Nova Biomedical please go to www.novabiomedical.com.
Nova Max® is a registered trademark of Nova Biomedical®.